Wolters Kluwer to divest its Pharma Solutions business

July 28, 2011

July 27, 2011.Wolters Kluwer, a market leader in the professional health content and clinical decision support market, today announced a plan to divest its Pharma-related business. The company is well-positioned to benefit from healthcare reform trends globally to support the Health division's growth strategy.

"The planned divestment of the Pharma business will focus our Health division on taking full advantage of our leading positions in professional information and clinical decision support solutions, one of the fastest growing areas of Health, to deliver enhanced value to our stakeholders," said Nancy McKinstry, CEO and Chairman of the Executive Board of Wolters Kluwer.


Industry News